PHASE-I STUDY OF ORAL DOXIFLURIDINE USING 2 SCHEDULES

被引：17

作者：

ALBERTO, P

WINKELMANN, JJ

PASCHOUD, N

PEYTREMANN, R

BRUYERE, A

RIGHETTI, A

DECOSTER, G

HOLDENER, EE

机构：

[1] UNIV GENEVA,HOP CANTONAL,DIV CARDIOL,CH-1211 GENEVA 4,SWITZERLAND

[2] F HOFFMANN LA ROCHE & CO LTD,DEPT CLIN RES,DIV ONCOL,CH-4002 BASEL,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 05期

关键词：

D O I：

10.1016/0277-5379(89)90139-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：905 / 908

页数：4

共 16 条

[1] PHASE-II STUDY OF DOXIFLURIDINE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].

ABELE, R ;

KAPLAN, E ;

GROSSENBACHER, R ;

SCHMID, HJ ;

CAVALLI, F .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (03) :333-336

[2] PHASE-II STUDY OF DOXIFLURIDINE IN ADVANCED COLORECTAL ADENOCARCINOMA [J].

ABELE, R ;

ALBERTO, P ;

KAPLAN, S ;

SIEGENTHALER, P ;

HOFMANN, V ;

RYSSEL, HJ ;

HARTMANN, D ;

HOLDENER, EE ;

CAVALLI, F .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :750-754

[3]

ALBERTO P, 1986, CANCER CHEMOTH PHARM, V16, P78

[4] A PHASE-II STUDY OF DOXIFLURIDINE IN PATIENTS WITH ADVANCED BREAST-CANCER [J].

ALBERTO, P ;

JUNGI, WF ;

SIEGENTHALER, P ;

MERMILLOD, B ;

OBRECHT, JP ;

DECOSTER, G ;

CAVALLI, F .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03) :565-566

[5] A RANDOMIZED COMPARISON OF DOXIFLURIDINE AND FLUOROURACIL IN COLORECTAL-CARCINOMA [J].

ALBERTO, P ;

MERMILLOD, B ;

GERMANO, G ;

KAPLAN, S ;

WEBER, W ;

JOSS, R ;

SPATI, B ;

MARTZ, G ;

CAVALLI, F .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03) :559-563

[6]

ALBERTO P, 1988, P ASCO, V7, P63

[7]

ARMSTRONG RD, 1988, CANCER RES, V43, P2525

[8]

AU JL, 1988, CANCER CHEMOTH PHARM, V22, P5

[9] TUMOR INHIBITORY EFFECTS OF A NEW FLUOROURACIL DERIVATIVE - 5'-DEOXY-5-FLUOROURIDINE [J].

BOLLAG, W ;

HARTMANN, HR .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) :427-432

[10]

BRUCKNER HW, 1974, CANCER, V33, P14, DOI 10.1002/1097-0142(197401)33:1<14::AID-CNCR2820330106>3.0.CO

← 1 2 →